Clinical Trials Sponsored by Xenikos

Total 10 results

Xenikos

Completed

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Graft vs Host Disease

Netherlands, Germany
Assistance Publique - Hôpitaux de Paris
Xenios AG

Recruiting

Effects of Blood Pulsatility on Von Willebrand Factor During ECCO2R (FLOW-ECCO2R)

Acute Respiratory Distress Syndrome | Pulmonary Disease | Extracorporeal CO2 Removal | Chronic Obstructive Pulmonary Disease Exacerbation

France
Xenios AG

Not yet recruiting

Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients (PulseSE)

Extracorporeal Membrane Oxygenation | Cardiogenic Shock | ECLS | VA ECMO

Germany
Xenios AG
MAXIS Medical

Completed

Synchronized Cardiac Assist for Cardiogenic Shock

Shock, Cardiogenic | High Risk Percutaneous Coronary Interventions

Germany
Eniko Vaszine Szabo

Enrolling by invitation

The Effectiveness of Hyperpure Chlorine Dioxide and Sodium Hypochlorite Irrigants in Endodontic Retreament in RCT

Persistent Infection | Periapical Lesion

Hungary
Xenios AG
Winicker Norimed GmbH

Recruiting

Early Extubation by ECCO2R Compared to IMV in Patients With Severe Acute Exacerbation of COPD (X-COPD)

COPD Exacerbation

Germany
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; Xenios AG

Recruiting

CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases (CORAIL)

COPD Acute Exacerbation

France
Xenikos
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Terminated

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) (2002)

Steroid-Refractory Acute Graft Versus Host Disease

United States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
Xenikos
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Terminated

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) (1802)

Steroid-Refractory Acute Graft Versus Host Disease

United States
Peter Rossing
University Medical Center Groningen; European Commission; Istituto Di Ricerche... and other collaborators

Completed

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria (PRIORITY)

Diabetic Retinopathy | Diabetic Nephropathy

Netherlands, Belgium, Spain, Czechia, Germany, United Kingdom, Denmark, Greece, Italy, Macedonia, The Former Yugoslav Republic of

Clinical Trials Sponsored by Xenikos

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations